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Purpose: This study was conducted to determine the association between the characteristics of calf muscle hemoglobin
oxygen saturation (StO2) and exercise performance in patients with intermittent claudication.
Methods: The study comprised 39 patients with peripheral arterial disease limited by intermittent claudication. Patients
were characterized on calf muscle StO2 before, during, and after a graded treadmill test, as well as on demographic and
cardiovascular risk factors, ankle-brachial index (ABI), ischemic window, initial claudication distance (ICD), and
absolute claudication distance (ACD).
Results: Calf muscle StO2 decreased 72%, from 55%  18% (mean SD) saturation at rest to the minimum value of 17%
19% saturation attained 459 380 seconds after the initiation of exercise. After exercise, recovery half-time of calf muscle
StO2 was attained at 129 98 seconds, whereas full recovery to the resting value was reached at 225 140 seconds. After
adjusting for sex, race, and grouping according to the initial decline constant in calf muscle StO2 during exercise, the
exercise time to minimum calf muscle StO2 was correlated with the ischemic window (r  0.493, P  .002), ICD (r 
0.339, P  .043), and ACD (r  0.680, P < .001). After treadmill exercise, the recovery half-time of calf muscle StO2
was correlated with the ischemic window (r  0.531, P < .001), ICD (r  0.598, P < .001), and ACD (r  0.491,
P  .003).
Conclusion: In patients limited by intermittent claudication, shorter ICD and ACD values are associated with reaching a
minimum value in calf muscle StO sooner during treadmill exercise and with having a delayed recovery in calf muscle2
StO2 after exercise. ( J Vasc Surg 2008;48:644-9.)Peripheral arterial disease (PAD) is prevalent in 16% of
the United States population aged older than 55 years, and
the symptom of intermittent claudication is prevalent in
5%.1 Intermittent claudication is ischemic muscular leg
pain that occurs during ambulation when the peripheral
circulation is inadequate to meet the metabolic require-
ment of the active leg musculature. Consequently, inter-
mittent claudication leads to ambulatory dysfunction2-5
and a decline in daily physical activities.6
The ankle-brachial index (ABI) is a standard outcome
measure to quantify vascular insufficiency in PAD patients.1,7
However, ABI is not a measure of exercise-mediated mus-
cular ischemia and is either modestly4,8,9 or poorly5,10,11
correlated with walking distances to onset and to maximal
pain during standardized treadmill tests. The ankle systolic
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644pressure measured after treadmill exercise is another stan-
dard outcome measure to assess vascular insufficiency,12-14
but it also does not provide real-time information on mus-
cular ischemia during exercise. In contrast, near infrared
spectroscopy (NIRS) is a relatively new, noninvasive tech-
nique that measures hemoglobin oxygen saturation (StO2)
of the calf musculature during exercise.15-22 The measure-
ment of calf muscle StO2 during ambulation provides in-
sight into the balance between oxygen delivery and oxygen
demand during exercise.
Calf muscle StO2 decreases more during exercise and
recovers more slowly in patients with intermittent claudi-
cation than in controls.19,21,23,24 However, less is known
about which characteristics of the exercise-mediated
changes in calf muscle StO2 are related to walking distances
during standardized treadmill exercise and to vascular in-
sufficiency in patients with intermittent claudication. The
purpose of this study was to determine the association
between calf muscle StO2 characteristics and exercise per-
formance in patients with intermittent claudication.
METHODS
Subject recruitment. Subjects aged between 50 and
90 years were evaluated in the General Clinical Research
Center at the University of Oklahoma Health Sciences
Center (HSC). Participants were recruited by referrals from
the HSC vascular clinic, as well as by newspaper advertise-
ments. The procedures used in this study were approved by
the Institutional Review Board at the University of Okla-
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each individual before investigation.
Screening. Individuals with intermittent claudication
secondary to vascular insufficiency were included in this
study if they met the following criteria:
1. a history of intermittent claudication,
2. ambulation during a graded treadmill test limited by
intermittent claudication,12 and
3. an ABI 0.90.1
Individuals were excluded from this study for the fol-
lowing criteria:
1. absence of PAD (ABI 0.90);
2. inability to obtain an ABI measure due to noncompress-
ible vessels;
3. asymptomatic PAD;
4. use of medications indicated for the treatment of inter-
mittent claudication (cilostazol and pentoxifylline) 3
months before investigation;
5. exercise tolerance limited by factors other than leg pain,
such as severe coronary artery disease, dyspnea, poorly
controlled blood pressure;
6. active cancer, renal disease, or liver disease,
7. calf skin fold50 mm because of potential interference
with the light path of the NIRS probe from penetrating
the subcutaneous tissue; and
8. pulse arterial oxygen saturation of the index finger
95% because of the potential deleterious effect on calf
muscle StO2 from poor pulmonary gas exchange.
A total of 39 individuals with intermittent claudication
were deemed eligible for this investigation, and 14 were
ineligible.
Medical history, physical examination, and anthro-
pometry. Demographic information, height, weight, car-
diovascular risk factors, comorbid conditions, claudication
history, blood samples, and a list of current medications
were obtained from a medical history and physical exami-
nation at the beginning of the study. During the physical
examination, arterial oxygen saturation was measured from
the index finger using a standard pulse oximeter. After-
wards, subcutaneous fat over the medial gastrocnemius
muscle was measured from a skin fold obtained by a trained
technician using a Lange skin fold caliper according to
standard guidelines,25 and waist and hip circumferences
were recorded.25
Gardner treadmill test. Patients performed a pro-
gressive, graded treadmill protocol (2 mph, 0% grade with
2% increase every 2 minutes) until maximal claudication
pain, as previously described.12 The initial claudication
distance (ICD), defined as the walking distance at which
the patient first experienced pain, and the absolute claudi-
cation distance (ACD), defined as the walking distance at
which ambulation could not continue due to maximal pain,
were both recorded to quantify the severity of claudication.
Exercise capacity was measured by oxygen uptake at peak
exercise with a Medical Graphics VO2000 metabolic sys-
tem (Medical Graphics Corp, St. Paul, Minnesota, Minn).Using these procedures, the test-retest intraclass reliability
coefficient is R  0.89 for ICD,12 R  0.93 for ACD,12
and R  0.88 for peak oxygen uptake.26
In addition, ABI measures were obtained from the
more severely diseased lower extremity before and 1, 3, 5,
and 7 minutes after each treadmill test, as previously de-
scribed.12,13 The reduction in ankle systolic blood pressure
after treadmill exercise from the resting baseline value was
quantified by calculating the area under the curve (AUC),
referred to as the ischemic window.27 Because the ischemic
window is a function of both PAD severity and the amount
of exercise performed, the ischemic window was divided by
ACD to normalize the ischemic window per meter walked.
Hemoglobin oxygen saturation of the
calf musculature
Instrumentation. Calf muscle StO2 was measured be-
fore, during, and after exercise using a continuous-wave,
NIRS spectrometer (InSpectra model 325; Hutchinson
Technology, Inc, Hutchinson, MN), an optical cable at-
tached to a 25-mm probe, InSpectra 2.0 software, and a
dedicated laptop computer. The noninvasive technique of
NIRS uses specific, calibrated wavelengths of near infrared
light to quantify the percentage of hemoglobin oxygen
saturation in the microvasculature of the tissue below the
NIRS probe, as well as a small contribution of intracellular
myoglobin. The degree of light absorption depends on the
amount of oxygen attached to the hemoglobin in the
arterioles, venules, and capillaries. Nonabsorbed light is
returned as an optical signal and analyzed to produce a ratio
of oxygenated hemoglobin to total hemoglobin, expressed
as percentage of StO2 saturation continuously displayed on
the spectrometer interfaced to a laptop computer. Conse-
quently, the NIRS technique is a measure of the balance
between local oxygen delivery and oxygen demand.
Calibration and measurements. Before the treadmill
test, the InSpectra machine was calibrated against low
(38%) and high (88%) reference standards of hemoglobin
oxygen saturation by placing the NIRS probe inside low
and high reference ports in an InSpectra System Check
device. After successful calibration of the unit, the 25-mm
NIRS probe was attached to the skin over the medial
gastrocnemius muscle of the more severely affected leg
using a double-sided adhesive light-excluding patch.16 The
more severely affected leg was defined as the more symp-
tomatic leg having the lower ABI value. Calf muscle StO2
values were obtained every 3.5 seconds throughout the
testing procedures, and the data file was then saved for
subsequent analyses to characterize the pattern of change in
calf muscle StO2 during and after treadmill exercise.
StO2 variables. A number of calf muscle StO2 vari-
ables were obtained before, during, and after treadmill
exercise, and are shown as different points on the curve in
the Fig. Before the treadmill test, a baseline measure of calf
muscle StO2 was obtained at rest as patients stood on the
treadmill for 2 minutes to allow for equilibration (point 1
shown in the Fig). During treadmill exercise, the minimum
StO2 value (point 2), the time taken to reach the minimum
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percentage drops in calf muscle StO2 from rest (point 1) to
the minimum exercise value (point 2), and the average rate
of decline from rest (point 1) to the minimum exercise
value (point 2) were obtained.
In addition, an exponential of the form ekt was fitted to
the data from the initial decline of StO2 from the resting
value by estimating k as the slope of ln(StO2) regressed on
time in seconds. Data for at least 15 seconds were included
in the model for each subject with additional adjacent times
included until a departure from linearity was indicated by
an increase in root mean square error. The value obtained
for k for each subject is referenced as the initial decline
constant (IDC). The resulting distribution of IDCs was
distinctly bimodal: 34 subjects (87%) had IDC values be-
tween 0.0990 and 0.0035 sec1, and 5 (13%) had
values of less than 0.1856 sec1. For analysis purposes,
the larger group was referenced as IDC group I, and the
smaller was referenced as IDC group II.
The time to reach minimum StO2 if the fitted IDC had
been maintained throughout exercise (time between point
1 and point 3) was recorded as the predicted time to reach
the minimum StO2. The StO2 exercise time delay was
calculated as the difference between the observed and pre-
dicted times to reach the minimum exercise StO2 value
(time between point 2 and point 3). Thus, StO2 exercise
Fig. Calf muscle hemoglobin oxygen saturation (StO2) ob-
tained before, during, and after treadmill exercise in a patient
with intermittent claudication. Œ, Exponential decline; 1, rest
StO2; 2, predicted time to minimum StO2; 4, end of exercise; 5,
half-recovery of StO2; 6, full recovery of StO2; 7, maximum
StO2.time delay represents the time in which StO2 declined at aslower rate than the IDC until the minimum StO2 value
was attained. The end of treadmill exercise was recorded
(point 4), as well as the StO2 values during recovery that
were one-half of the resting value (point 5), the full resting
value (point 6), and the maximal value (point 7). The
recovery times for StO2 to reach one half of the resting
StO2 value (recovery half-time, measured as the time be-
tween point 4 and point 5), the full resting StO2 value (full
recovery time, measured as the time between point 4 and
point 6), and the maximum StO2 value (time between
point 4 and point 7) were calculated.
Statistical analyses. Preliminary examination of data
revealed that many of the variables of interest had apprecia-
bly different mean values for IDC groups, for gender
groups, and for Caucasian and African American groups.
To guard against these differences distorting correlation
estimates, partial correlation coefficients were calculated by
adjusting for these three dichotomous variables. We also
noted that the distributions for some of the variables were
markedly asymmetric. To minimize the possible distorting
effect of extreme values, both Pearson and Spearman partial
correlation coefficients were computed for each pair of
variables of interest, with Spearman used only if the two
estimates differed by 0.1. All analyses were performed
using the NCSS statistical package (NCSS, Kaysville,
Utah). Statistical significance was set at P  .05. Measure-
ments are presented as means  standard deviations.
RESULTS
The clinical characteristics of the patients with intermit-
tent claudication are shown in Table I. The group consisted
of a similar proportion of men and women, as well as
Caucasians and African Americans. The ABI, ICD, ACD,
and cardiovascular risk factors are typical for those with
Table I. Clinical characteristics of 39 peripheral arterial
disease patients with intermittent claudication
Variables
Values,
mean (SD) and %
Age, years 68 (10)
Weight, kg 84.6 (18.5)
Body mass index 30.2 (7.4)
Ankle-brachial index 0.64 (0.18)
Ischemic window (min  mm Hg/m) 0.48 (0.41)
ICD (meters) 274 (178)
ACD (meters) 480 (273)
Peak oxygen uptake, (mL/kg/min) 12.6 (4.3)
Sex (% men) 54
Race (% Caucasian) 49
Current smoking (% yes) 38
Diabetes (% yes) 38
Hypertension (% yes) 87
Dyslipidemia (% yes) 87
Obesity (% yes)a 44
ACD, absolute claudication distance; ICD, initial claudication distance; SD,
standard deviation.
aObesity was defined as having a body mass index 30 kg/m2.intermittent claudication. The calf muscle StO2 measures
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muscle StO2 decreased 72% from rest to the minimum
value attained 459 seconds after the initiation of exercise.
The predicted time to reach the minimum StO2 value was
126 seconds, and the StO2 exercise time delay was 333
seconds. At the completion of exercise, the time for calf
muscle StO2 to increase to half of the resting value was 129
seconds, whereas full recovery was reached at 225 seconds.
Calf muscle StO2 continued to increase to an average maxi-
mum value of 82% saturation 665 seconds after completion of
exercise. The two IDC groups were similar on all variables
reported in Tables I and II, except that IDC group II (n 5)
had lowerABI (0.470.11 vs 0.660.17,P .015) values,
a higher ischemic window (0.87 0.41 vs 0.36 0.31, P
.009), and a shorter time delay in reaching the minimum
exercise StO2 (0.14 0.46 sec vs 382.13 328.07 sec, P
.002) than the ICD group I (n 34).
The partial correlation coefficients between calf muscle
StO2measures and exercise performancemeasures are listed in
Table III. After adjusting for sex, race, and IDC groups, the
measured exercise time to minimum calf muscle StO2 was
negatively correlated with the ischemic window (P  .002)
and was positively correlated with ICD (P .043) and ACD
(P  .001). The StO2 exercise time delay was negatively
correlated with ischemic window (P .004) and positively
correlated with ABI (P  .024) and ACD (P  .001). In
addition, the minimum StO2 value attained during exercise
was positively correlated with ICD (P  .015), the IDC was
positively associated with ACD (P .048), and the average rate
of decline in calf muscle StO2 during exercise was positively
correlated with the ischemic window (P .004) and negatively
associated with ACD (P .001).
After treadmill exercise, the recovery half-time of calf
Table II. Measures of calf muscle hemoglobin oxygen
saturation in 39 peripheral arterial disease patients with
intermittent claudication
Variables Values, mean (SD)
StO2 at rest, % saturation 55 (18)
Initial decline constant, sec1 0.052 (0.088)
Minimum exercise StO2, % saturation 17 (19)
Predicted time to minimum exercise StO2,
sec 126 (104)
Measured time to minimum exercise StO2,
sec 459 (380)
Time delay in reaching minimum exercise
StO2, sec 333 (332)
Absolute drop in StO2 during exercise,
% saturation 38 (18)
Percentage drop in StO2 during exercise, % 72 (28)
Average rate of decline in StO2 from rest
to minimum exercise value,
% saturation/s 0.306 (0.519)
Recovery half-time of StO2, sec 129 (98)
Recovery time of StO2, sec 225 (140)
Recovery time to maximal StO2, sec 665 (705)
Maximum recovery StO2, % saturation 82 (20)
SD, standard deviation; StO2, hemoglobin oxygen saturation.muscle StO2 was positively correlated with the ischemic win-dow (P  .001) and negatively correlated with ICD (P 
.001) andACD(P .003). Similarly, the recovery time of calf
muscle StO2 to reach the resting value was positively corre-
lated with the ischemic window (P  .007) and negatively
associated with ICD (P  .001) and ACD (P  .005). The
recovery time to maximal calf muscle StO2 was negatively
correlated with ICD (P .006), and the maximal calf muscle
StO2 value was positively correlated with ICD (P .008).
The partial correlation coefficients between measures
of ABI and ischemic window with exercise performance are
reported in Table IV. ABI measurements obtained at rest
and after treadmill exercise were positively associated with
ICD and ACD (P  .05), and the ischemic window was
negatively correlated with ICD (P  .05) and ACD (P 
.001).
DISCUSSION
The major findings of this investigation are that (1)
shorter exercise time for calf muscle StO2 to reach a mini-
mum value during treadmill walking is associated with
shorter ICD and ACD as well as a greater ischemic window
after exercise, and (2) slower recovery in calf muscle StO2
after exercise is associated with shorter ICD and ACD, and
greater ischemic window after exercise.
Change in calf muscle StO2 during exercise.
Although calf muscle StO2 declines during treadmill exer-
cise in patients with intermittent claudication, eventually
reaching a minimum plateau before the end of exer-
cise,15,20 less attention has been given to the characteristics
of the exercise-mediated decline. A key measure of calf
muscle StO2 during exercise is the observed time to reach
the minimum StO2 value. The time to minimum calf StO2
during exercise was positively associated with ICD and
ACD and negatively associated with the ischemic window,
suggesting that patients with greater impairment in exercise
performance have faster deoxygenation of the active isch-
emic musculature during standardized treadmill walking.
This observation supports previous reports that PAD patients
have greater absolute and percentage declines in calf muscle
StO2 during treadmill walking than controls,
19,21,23,24 and
that the decline in calf muscle StO2 occurs early in exercise
and does not increase until cessation of exercise in which
there are two different recovery patterns.15,20 The current
study extends these findings by demonstrating that the key
variable in the decline in calf muscle StO2 during exercise is
the time taken to reach the minimum value, because pa-
tients who reach the minimum calf muscle StO2 sooner
experience ICD and ACD sooner as well.
Another important measure of calf muscle StO2 during
exercise is the StO2 exercise time delay between the pre-
dicted and observed times to reach the minimum StO2
value. This measure is determined by first calculating the
predicted time to minimum StO2 based on the exponential
decline in calf muscle StO2 at the onset of exercise. The
StO2 exercise time delay may reflect an increase in capillary
blood volume during exercise,24 thereby changing the
exponential decline in StO2 occurring at the onset of exer-
cise to a slower rate of decline during the remainder of
l corr
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ciated with ABI and ACD and was negatively associated
with the ischemic window, suggesting that the patients
with greater PAD severity and impairment in exercise per-
formance have faster deoxygenation of the calf muscle,
perhaps due to smaller increases in capillary blood volume
during standardized treadmill exercise.
It is interesting to note that the StO2 exercise time
delay is associated with ABI, ACD, and ischemic window
primarily due to differences in the observed time to mini-
mum calf StO2 rather than the predicted time. We found
that neither the IDC nor the predicted time to minimum
StO2 during exercise was associated with any of the vascular
and exercise performance measures, except that IDC was
positively associated with ACD. These findings suggest that
the exponential decline in StO2 at the onset of exercise
either is not predictive or is positively associated with
claudication distances (ie, a more negative IDC is associ-
ated with shorter ACD). This does not support a previous
report that found that PAD patients have a slower rate of
Table III. Association between measures of calf muscle he
peripheral arterial disease patients with intermittent claudic
Variables
StO2 at rest
Initial decline constant
Minimum exercise StO2
Predicted time to minimum exercise StO2
Measured time to minimum exercise StO2
Time delay in reaching minimum exercise StO2
Absolute drop in StO2 during exercise
Relative drop in StO2 during exercise
Average rate of decline in StO2 from rest to minimum exercise val
Recovery half-time of StO2
Recovery time of StO2
Recovery time to maximal StO2
Maximum recovery StO2
ABI, Ankle-brachial index; ACD, absolute claudication distance; ICD, initial c
Values are either Pearson partial correlation coefficients or aSpearman partia
bP  .05; cP  .01; dP  .001.
Table IV. Association between measures of
ankle-brachial index and ischemic window with exercise
performance in 39 peripheral arterial disease patients with
intermittent claudication
Variables ICD ACD
ABI: rest 0.402a 0.438b
Ischemic window 0.451b 0.673c
ABI: 1 min recovery 0.391a,d 0.425b
ABI: 5 min recovery 0.450b,d 0.442b
ABI: 15 min recovery 0.410a 0.464b
ABI, Ankle-brachial index; ACD, absolute claudication distance; ICD,
initial claudication distance.
aP  .05; bP  .01; cP  .001.
Values are either Pearson partial correlation coefficients or dSpearman
partial correlation coefficients adjusted for sex, race, and IDC group.decline in StO2 (ie, less negative) during the onset oftreadmill walking than controls17 and during isometric
contraction performed at very low intensities of 5% and 10%
maximal voluntary contraction.18 We calculated the StO2
decline differently to best fit the exponential drop at the
onset of exercise, thus making comparisons difficult. How-
ever, when the decrease in calf muscle StO2 is expressed as
an average rate of decline during exercise, our finding that
worse exercise performance is associated with an acceler-
ated average drop in StO2 supports previous work.
23
Change in calf muscle StO2 during recovery. Calf
muscle StO2 increases after treadmill exercise in patients
with intermittent claudication, eventually reaching a maxi-
mum value. The increase in calf muscle StO2 is a reflection
of oxygen delivery exceeding oxygen extraction. Key mea-
sures of calf muscle StO2 during recovery include the time
for StO2 to reach one-half of the resting StO2 value and the
time to reach the full resting StO2 value. The recovery times
to one-half and to full recovery of calf muscle StO2 were
negatively associated with ICD and ACD, and positively
associated with ischemic window, suggesting that patients
with worse exercise performance and vascular insufficiency
have delayed StO2 recovery times. Our findings support
previous reports that PAD patients have longer StO2 recov-
ery times than controls19,21,23,24 and extends this observa-
tion by showing that prolonged recovery times of calf
muscle StO2 after treadmill exercise occur in PAD patients
with greater exercise limitations.
This study has some limitations that are associated with
the measurement of calf muscle StO2. Although the calf
muscle StO2 primarily reflects the relative balance between
oxygen delivery and oxygen utilization of the local tissue,
the contribution of myoglobin to the StO2 measurement
cannot be excluded, especially during the onset on exer-
cise.17 However, any contribution that local myoglobin
may have on the calf muscle StO2 should be minimal
beyond the initial phase of exercise.
Another limitation with the StO2 measure is that the
lobin oxygen saturation and exercise performance in 39
ABI IW ICD ACD
0.059 0.005a 0.294a 0.043
0.052a 0.287 0.172 0.331b
0.167a 0.004a 0.403b 0.136a
0.206 0.070 0.205a 0.030a
0.289 0.493a,c 0.339b 0.680d
0.376b 0.464a,c 0.261a 0.659d
0.105a 0.066 0.150a 0.010a
0.202 0.016a 0.475c 0.157a
0.258 0.471a,c 0.172 0.583a,d
0.316 0.531a,d 0.598d 0.491a,c
0.280 0.461a,c 0.540d 0.475a,c
0.161 0.275 0.454a,c 0.261
0.229 0.029 0.448a,c 0.145
tion distance; IW, ischemic window; StO2, hemoglobin oxygen saturation.
elation coefficients adjusted for sex, race, and IDC group.mog
ation
ue
laudicaredistribution of oxyhemoglobin and deoxyhemoglobin in
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blood that have different oxygen saturations.17 The subcu-
taneous fat thickness also may interfere with the calf muscle
StO2 measurement. However, it is unlikely that this affected
the results because no relationship exists between the calf skin
fold and calf muscle StO2 in PAD patients
16 and because only
patients with calf skin folds of50 mm participated. Because
subcutaneous tissue is only half the thickness of the skin fold
measurement, the penetration of the light path of the NIRS
probe to a depth of 25 mm should go beyond the subcutane-
ous tissue into the calf musculature.
Finally, the results of this study are only applicable to
PAD patients who are limited by intermittent claudication
and thus may not be generalizable to patients with different
symptomatology.
Despite these potential limitations, themeasurement of
calf muscle StO2 provides real-time information during
exercise about the balance between oxygen delivery and
oxygen demand of the calf musculature. Thus, this tech-
nique may be a useful research tool to evaluate the efficacy
of interventions designed to improve claudication and pe-
ripheral circulation.
CONCLUSIONS
In patients limited by intermittent claudication, shorter
ICD and ACD values are associated with reaching a mini-
mum value in calf muscle StO2 sooner during treadmill
exercise and with having a delayed recovery in calf muscle
StO2 after exercise. The implication is that calf muscle StO2
quantifies the ischemic response to exercise in patients with
claudication. Further work is needed to establish whether
calf muscle StO2 changes in response to various interven-
tions targeted to improve exercise performance in patients
with intermittent claudication.
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